Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | DHFR | P00374 | 8/20 | 0.44 |
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | BAD | Q92934 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4974372 | 0.76 | BCL2L1 (0.60) | KDM4EALDH1A1POLBNOS3NOS1 | |
| SCHEMBL17350713 | 0.76 | CYP2D6 (0.51) | KDM4EALDH1A1POLBDHFRNOS3 | |
| Bromide SCHEMBL7104246 | 0.74 | BCL2L1 (0.58) | KDM4EALDH1A1POLBNOS3NOS1 | |
| SCHEMBL29488244 | 0.72 | BCL2L1 (0.54) | NOS3BCL2L1BAD | |
| SCHEMBL17698887 | 0.72 | BCL2L1 (0.54) | NOS3BCL2L1BAD | |
| SCHEMBL3397315 | 0.72 | ADORA2A (0.40) | KDM4EALDH1A1POLBDHFRNOS3 | |
| SCHEMBL4354112 | 0.71 | FGFR1 (0.56) | DHFRFGFR1 | |
| SCHEMBL4464780 | 0.70 | FGFR1 (0.55) | DHFRFGFR1 | |
| Hydrochloric Acid SCHEMBL4528670 | 0.70 | DHFR (0.54) | DHFR | |
| SCHEMBL3959532 | 0.69 | DHFR (0.54) | DHFRNOS3NOS1NOS2FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2344476-A2 | TRICYCLIC CARBAMATE JAK INHIBITORS | Rigel Pharmaceuticals, Inc. (US) | 2011-07-20 | — | — | EP | claimed |
| WO-2010039518-A2 | TRICYCLIC CARBAMATE JAK INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2010-04-08 | — | — | WO | claimed |
| EP-2344476-A2 | TRICYCLIC CARBAMATE JAK INHIBITORS | Rigel Pharmaceuticals, Inc. (US) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010039518-A2 | TRICYCLIC CARBAMATE JAK INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2010-04-08 | — | — | WO | disclosed |